Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Touzot

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Cell Reports. Medicine|January 27, 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapySteicy Sobrino, Alessandra Magnani, Michaela Semeraro, et al.
Blood|December 2, 2010
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous, et al.
JAMA|April 22, 2015
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndromeSalima Hacein-Bey Abina, H Bobby Gaspar, Johanna Blondeau, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
Human Mutation|May 4, 2019
Functional classification of ATM variants in ataxia-telangiectasia patientsAlice Fiévet, Dorine Bellanger, Guillaume Rieunier, et al.
Journal of Clinical Immunology|July 9, 2020
Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic LymphohistiocytosisAnnaliesse Blincoe, Maximilian Heeg, Patrick K Campbell, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2024
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium studyEyal Grunebaum, Danielle E Arnold, Brent Logan, et al.
Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cell Reports. Medicine|January 27, 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapySteicy Sobrino, Alessandra Magnani, Michaela Semeraro, et al.
Blood|December 2, 2010
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous, et al.
JAMA|April 22, 2015
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndromeSalima Hacein-Bey Abina, H Bobby Gaspar, Johanna Blondeau, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
Human Mutation|May 4, 2019
Functional classification of ATM variants in ataxia-telangiectasia patientsAlice Fiévet, Dorine Bellanger, Guillaume Rieunier, et al.
Journal of Clinical Immunology|July 9, 2020
Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic LymphohistiocytosisAnnaliesse Blincoe, Maximilian Heeg, Patrick K Campbell, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2024
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium studyEyal Grunebaum, Danielle E Arnold, Brent Logan, et al.
Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.
The New England Journal of Medicine|October 9, 2014
A modified γ-retrovirus vector for X-linked severe combined immunodeficiencySalima Hacein-Bey-Abina, Sung-Yun Pai, H Bobby Gaspar, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
Pageof 6